Previous Event

Vaccine Allocation and Social Justice

December 1, 2020 - December 9, 2020

Overview

Safe and effective Covid-19 vaccines are now potentially within reach. Yet, because of production bottlenecks and other constraints, for months, supply will not meet demand. Rationing will be inevitable. A major theme in emerging policy guidance is that vaccines should be allocated in ways that reduce inequities. More concretely, vaccine allocation needs to respond directly to the fact that disadvantaged groups—and especially racial and ethnic minorities—have been hit much harder by Covid-19 in terms of unemployment, illness, and deaths compared to the more privileged white majority. How can federal and state policy makers ensure vaccine allocation reduces inequities and contributes to social justice as they scramble to prepare for allocation efforts that are unprecedented in their logistical complexity?

To advance debate and planning, policy makers, public health workers, community leaders, activists, researchers, reporters, and the general public are invited to hear from leading experts about concrete steps that can be taken to dramatically improve the chances of equitable vaccine allocation. Of particular focus is ensuring that vulnerable groups that have often experienced—and experience—structural racism and other forms of systemic injustice are central to this effort.

The co-hosts Ariadne Labs, Boston College, the Harvard Chan School of Public Health, the International Society for Priorities in Health, MIT, O’Neil Institute/Georgetown, The University of Pennsylvania’s Department of Medical Ethics and Health Policy, and the Leonard Davis Institute of Health Economics, invite you to a 4-part symposium and seminar series on two days.

Presented By

Speakers

  • Saad Omer
    Director, Yale Institute for Global Health and Professor of Medicine

    Yale University

  • Michelle Williams
    Dean of the Faculty and Professor in Public Health & Intl. Development

    Harvard T.H. Chan School of Public Health, Harvard Kennedy School

  • Lawrence Gostin
    University Professor and Faculty Director of the O'Neill Institute

    Georgetown Law

  • Parag Pathak
    Director

    Blueprint Labs

  • Tayfun Sönmez
    Professor of Economics

    Boston College

  • M. Utku Ünver
    Professor of Economics

    Boston College

    Event Organizer

  • Harald Schmidt
    Assistant Professor of Medical Ethics & Health Policy

    University of Pennsylvania​

    Event Organizer

  • Dayna Bowen Matthew
    Dean and Professor

    George Washington University School of Law

  • Caroline Johnson
    Deputy Health Commissioner and Acting Director, Division of Disease Control

    Philadelphia Dept. of Public Health

  • Nicole Lurie
    Strategic Advisor to the CEO

    Coalition for Epidemic Preparedness Initiatives

    Former Asst. Secretary for Preparedness & Response, Department of Health and Human Services

  • Paul Offit
    Director of Vaccine Eduction Center and Professor of Pediatrics

    Division of Infectious Diseases, Children's Hospital of Philadelphia ​

  • Alison Buttenheim
    Associate Professor of Family & Community Health and Director of Engagement at Penn LDI

    University of Pennsylvania ​

  • Atul Gawande
    Founder and Chair of Ariadne Labs and Professor

    Harvard T.H. Chan School of Public Health Harvard Medical School

  • Rebecca Weintraub
    Assistant Professor of Medicine at Harvard Medical School and Associate Physician

    Brigham & Women's Hospital

    Event Organizer

  • Kate Miller
    Senior Scientist

    Ariadne Labs

  • Nancy McClung
    Epidemiologist

    CDC Vaccine Task Force

  • Mary Ann Cooney
    VP, Health Equity

    Association of State and Territorial Health Officials

  • Michelle Fiscus
    Medical Director, Vaccine-Preventable Diseases and Immunization Program

    Tennessee Department of Health

  • Erica Pan
    Acting State Health Officer and Epidemiologist

    Center for Infectious Diseases, California Department of Public Health

  • Heidi Clark
    Chief

    Division of Infectious Diseases, Office of Health Protection, Illinois Department of Public Health

  • Kjell Arne Johannson
    Chair, International Society for Priorities in Health and Professor

    University of Bergen, Bergen Center for Ethics & Priority Setting

  • Ruth Faden
    Member, World Health Organization Strategic Advisory Group of Experts (SAGE) Working on Covid-19 Vaccines and Professor of Biomedical Ethics​

    Johns Hopkins University

  • Priyadarshini Chidambaram

    Madras Medical College

  • Anant Bhan
    Adjunct Professor and Researcher

    Yenepoya University

  • Arzoo Ahmed
    Research Officer

    Nuffield Council on Bioethics

  • Miqdad Asaria
    Assistant Professorial Research Fellow

    LSE Health

  • Prashant Yadav
    Senior Fellow, Center for Global Development and Affiliate Professor of Technology & Operations Management

    INSEAD

  • Austen Davis
    Senior Advisor, Global Health Section

    Norwegian Agency for Development Cooperation (NORAD)

Agenda

December 4, 2020December 9, 2020
Session OneSession TwoSession Three
Back to agenda
Session One

December 4, 2020

Practical, legal, and ethical ways of allocating vaccines equitably using novel approaches: an overview

10:30-11:55am ET
Web Conference

Back to agenda
Session Two

December 4, 2020

Addressing Challenges in Distribution and Uptake

12-1pm ET
Web Conference

Back to agenda
Session Three

December 4, 2020

In the Midst of Scarcity: How Leaders are Preparing Systems for Equitable Vaccine Allocation

1:05-2:30pm ET
Web Conference

Session Four
Back to agenda
Session Four

December 9, 2020

Social Justice and domestic vaccine allocation: perspectives from a global advisory body, low- middle- and high-income countries, and a funding agency

9:00-11:30am ET
Web Conference

Session One


Why allocating in ways that reduces, rather than maintains (or worse, exacerbates), inequities matters now

Saad Omer, Advisor, Strategic Advisory Group of Experts on Immunization (SAGE), World Health Organization

Michelle Williams, Dean, Harvard T.H. Chan School of Public Health

Practical and legal aspects of using different statistical measures of disadvantage

Lawrence Gostin, Director, O’Neill Institute for National and Global Health Law

Read the paper

How different adjustments to allocation frameworks impact vaccine distribution to disadvantaged populations

Parag Pathak, Professor of Economics, MIT

M Utku Ünver, Professor of Economics, Boston College

Tayfun Sönmez, Professor of Economics, Boston College

Read the paper

Read the paper

Read the paper

Normative reference points for pragmatic adjustments

Harald Schmidt, Assistant Professor of Medical Ethics & Health Policy, University of Pennsylvania

Read the paper

Read the paper

Slides

Session Closing & Next Steps


Session Two


Addressing Challenges in Distribution and Uptake (Panel discussion)

Dayna Bowen Matthew, Dean, George Washington University School of Law

Caroline Johnson, Deputy Health Commissioner, City of Philadelphia

Nicole Lurie, Strategic Advisor to the CEO, Coalition for Epidemic Preparedness Initiatives

Paul Offit, Director of the Vaccine Education Center, Children’s Hospital of Philadelphia

Alison Buttenheim, Director of Engagement, Leonard Davis Institute of Health Economics


Session Three


Opening

Atul Gawande, Founder and Chair, Ariadne Labs

States and other jurisdictions’ initial vaccine allocation plans

Rebecca Weintraub, Assistant Professor, Harvard Medical School, Ariadne Labs

Kate Miller, Senior Scientist, Ariadne Labs

Read the paper

The ethical framework of the Advisory Committee on Immunization Practices

Nancy McClung, Epidemiologist, CDC Vaccine Task Force

Equity and vaccine allocation – ASTHO perspective 

Mary Ann Cooney, VP, Health Equity, Association of State and Territorial Health Officials

Equity and vaccine allocation – State perspective: Tennessee

Michelle D. Fiscus, Medical Director,  Vaccine-Preventable Diseases and Immunization Program, Tennessee Department of Health

Slides

Equity and vaccine allocation – State perspective: California 

Erica Pan, Acting State Health Officer, California State

Equity and vaccine allocation – State perspective: Illinois

Heidi Clark, MPH , Chief, Division of Infectious Diseases, Office of Health Protection, Illinois Department of Public Health

Closing

Rebecca Weintraub, Assistant Professor, Harvard Medical School, Ariadne Labs

Slides


Session Four


Opening  

Kjell Arne Johannson, Chair, International Society for Priorities in Health

Harald Schmidt, Assistant Professor of Medical Ethics & Health Policy, University of Pennsylvania

Slides

National Equity and WHO SAGE Guidance

Ruth Faden, Advisor, Strategic Advisory Group of Experts on Immunization (SAGE), World Health Organization

United Kingdom

Arzoo AhmadResearch Officer, Nuffield Council on Bioethics

Miqdad AsariaAssistant Professorial Research Fellow, LSE Health

India

Priyadarshini  Chidambaram, Madras Medical College

Anant Bhan, Adjunct Professor and Researcher, Yenepoya University

Equity and supply chain management

Prashant Yadav, Senior Fellow, Center for Global Development Funding agency
Austen Davis, Senior Advisor, Global Health Section, NORAD

Closing

Rebecca Weintraub, Assistant Professor, Harvard Medical School, Ariadne Labs